The cluster of open-market purchases by two directors who are also 10% owners, without 10b5-1 plans, suggests confidence in the company's near-term prospects. Monitor for any upcoming catalysts such as trial data or partnership announcements that may have motivated the buying.
Price Chart
How similar events traded
Executive Summary
Two directors and 10% owners at Electra Therapeutics made open-market purchases totaling $537K over a 7-day window, with OrbiMed Advisors LLC buying in multiple tranches at prices ranging from $7.31 to $8.45. The cluster represents about 0.1% of market cap, a modest but notable signal from insiders who are also major shareholders.
Key Financial Metrics
Key Facts
- Two directors/10% owners purchased shares in the open market over 7 days
- Total open-market purchases: $537K (0.1% of $516M market cap)
- OrbiMed Advisors LLC bought in 5 tranches from $7.31 to $8.45 per share
- Gordon Carl L bought 30,891 shares at $7.31 on Nov 5
- No 10b5-1 plans were used for any of the purchases
- Recent 30-day insider activity: 10 buys totaling $3.0M prior to this cluster
Financial Impact
$537K in open-market purchases by two directors/10% owners
Risk Factors
- The total dollar amount is modest relative to market cap (0.1%), limiting the signal strength
- No company filings or events were provided to explain the insider buying
- Insider purchases at declining prices could indicate value buying rather than a near-term catalyst
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ETRA-1794359428068 |
Track record
15 reports on ETRA
3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +5.38% at T+1 after the Nov 5, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 10, 20261d ago Insider Cluster Bullish 4/10 Viewing Entry $7.80 Now $7.99 +2.44% settles Nov 12
- Nov 5, 20266d ago Insider Cluster Bullish 4/10 Entry $7.80 to $8.22 Now $7.99 +2.44% ▲ +5.38% +3.02% vs SPY
- Oct 29, 202613d ago SC 13G Neutral 4/10 Entry $8.10 to $7.31 Now $7.99 −1.36% ▼ −9.75% −9.27% vs SPY
- Sep 28, 20266w ago SC 13G Neutral 3/10 Entry $11.35 to $11.25 Now $7.99 −29.60% ▼ −0.88% −0.68% vs SPY
- Sep 28, 20266w ago SC 13G Neutral 3/10 Entry $11.35 to $11.25 Now $7.99 −29.60% ▼ −0.88% −0.68% vs SPY
- Sep 25, 20266w ago SC 13D Neutral 5/10 Entry $11.32 to $11.35 Now $7.99 −29.42% ▲ +0.27% +0.45% vs SPY
- Sep 23, 20267w ago Insider Cluster Bullish 6/10 Entry $11.82 to $11.55 Now $7.99 −32.40% ▼ −2.28% −2.83% vs SPY
- Sep 21, 20267w ago 3 Neutral 2/10 Entry $13.62 to $12.67 Now $7.99 −41.34% ▼ −6.97% −6.25% vs SPY
- Sep 18, 20267w ago 424B4 Bullish 7/10 Entry $13.92 to $13.62 Now $7.99 −42.60% ▼ −2.16% −2.14% vs SPY
- Sep 18, 20267w ago 3 Neutral 3/10 Entry $13.92 to $13.62 Now $7.99 −42.60% ▼ −2.16% −2.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers